rediff.com
e.g. Tata motors, Reliance MF, 500570
MPS Pharma Ltd. - Research Center
531686 ADVIKLA Group (XT) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20
Sales - - 0.03 - -
Operating profit -0.40 -0.41 -0.35 -0.32 -0.30
Interest - - - - -
Gross profit -0.31 -0.41 -0.35 -0.07 -0.29
EPS (Rs) -0.19 -0.25 0.08 -0.15 -0.28
Half yearly  results in details
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20
Other income 0.09 - - 0.25 0.01
Stock adjustment - - - - -
Raw material - - 0.02 - -
Power and fuel - - - - -
Employee expenses 0.26 0.23 0.21 0.21 0.19
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 0.14 0.18 0.16 0.11 0.10
Provisions made - - - - -
Depreciation 0.07 0.07 0.26 0.26 0.28
Taxation -0.01 -0.01 -0.76 -0.03 -0.04
Net profit / loss -0.37 -0.48 0.15 -0.29 -0.53
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 19.11 19.11 19.11 19.11 19.11
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) - - -1093.52 - -
GPM (%) - - -951.63 - -
NPM (%) - - 407.07 - -
Close
Add MPS Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add MPS Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close